Medicure Inc's stock experienced a remarkable rally, gaining over 23% in a single trading session.
In yesterday's trading session, Medicure Inc (MPH.V) saw its stock price increase by an impressive 23.16%, closing at CA$2.34. This surge in value highlights the stock's volatility and potential interest among investors in the small-cap sector.
Advertisement
Medicure Inc
MPH.V
MPH.V
Medicure Inc
WealthAwesomeMarket cap
$28.07M
52W high
$2.74
52W low
$0.85
1W change
+9.16%
Beta
1.27
Analyst Price Targets
Based on analyst covering MPH · as of Sep 17, 2026
Wall Street analysts forecast MPH stock price to rise 2.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.80
+2.2% Upside
Current Price
C$2.74
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MPH's historical volatility
30-Day Vol
123.3%
Annualized
90-Day Vol
137.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$3.28
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.91 | C$1.90 – C$4.45 |
| 60 trading days | C$3.09 | C$1.69 – C$5.63 |
| 90 trading days | C$3.28 | C$1.57 – C$6.85 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Medicure's recent stock performance may indicate growing investor confidence, but potential buyers should remain cautious given the company's limited coverage and financial challenges.
Medicure Inc's stock jumped 23.16% yesterday
With a market cap of CA$26,090,784, Medicure remains a speculative investment, particularly given its lack of profitability.
Bull case
The significant price increase suggests that investors are responding positively to Medicure's strategic initiatives. The company's expansion into the pharmacy business could open up new revenue streams in the future.
Bear case
Despite the surge, Medicure's negative profit margin and small market cap raise concerns about its long-term viability and ability to sustain growth.
Market Reaction
Advertisement
The sharp increase in Medicure's stock price reflects a positive market reaction, likely driven by speculative trading. Investors may be positioning themselves ahead of potential announcements or developments related to the company's operations.
Company Fundamentals
Despite the stock's impressive performance, Medicure's fundamentals present a mixed picture. With a negative profit margin of -23.23% and no dividend yield, investors should carefully consider the risks associated with investing in a company of this size. For more insights, check out the latest on Medicure's financial results.
Looking Ahead
As Medicure continues to navigate its growth strategy, including its expansion into the pharmacy business, investors will be watching closely for any updates that could impact the stock's trajectory. Stay informed about the company's developments by visiting their official website.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
